semaglutide and concerta Weight Loss Liraglutide vs Semaglutide vs GLP-1

What the New Research Shows Published in Nature Medicine in June 2026, the phase 2 EMBRAZE trial examined the combination of tirzepatide and apitegromab, an investigational monoclonal antibody that selectively inhibits myostatin activation

Body weight changes were non-significantly and weakly correlated with changes in whole-body BMD, leg BMD, and lumbar spine BMD

A real-world analysis of approximately 8,000 patients from the Cleveland Clinic found considerably less weight regain than clinical trial data would predict largely because many real-world patients transition to another weight-loss agent, restart semaglutide, or maintain structured lifestyle interventions after stopping

Consequently, we explore in more detail how sensory science and quality planning can help you enhance and maintain product quality, and how our consultancy, guidance and training in this area can support you with this

Makaronidis obtained funding from commercial organizations for the purpose of organizing conferences and educational events on behalf of the Association for the Study of Obesity (UK) in a voluntary role as the organizations sponsorship lead in 2025